HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: 2383042020v1 239/1/232    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fushimi, Y. Articles by Togashi, K. Search for Related Content PubMed PubMed Citation Articles by Fushimi, Y. Articles by Togashi, K.

Comparison of 3.0- and 1.5-T Three-dimensional Time-of-Flight MR Angiography in Moyamoya Disease: Preliminary Experience¹

¹ From the Department of Diagnostic Imaging and Nuclear Medicine (Y.F., Y.M., T.O., M.K., A.Y., K.T.), Department of Neurosurgery (K.K., K.N., N.H.), and Human Brain Research Center (T.H., H.F.), Kyoto University Graduate School of Medicine, 54 Shogoin-Kawaharacho, Sakyo-ku, Kyoto, 606-8507, Japan. From the 2005 RSNA Annual Meeting. Received November 29, 2004; revision requested January 20, 2005; revision received April 3; final version accepted May 2. Supported in part by a grant from the Ministry of Education Culture, Sports, Science and Technology, Japan. Address correspondence to Y.M. (e-mail: mikiy{at}kuhp.kyoto-u.ac.jp).

Purpose: To prospectively compare 3.0- and 1.5-T three-dimensional (3D) time-of-flight (TOF) magnetic resonance (MR) angiography in patients with moyamoya disease, with special emphasis on the visualization of abnormal netlike vessels (moyamoya vessels).

Materials and Methods: Study protocols were approved by the local ethics committee; written informed consent was obtained from all patients. The study included 24 consecutive patients with moyamoya disease (four male and 20 female patients). Patients ranged in age from 17 to 66 years (mean age, 41 years). Moyamoya disease had been diagnosed in all patients before they were entered into the study. All patients underwent 3D TOF MR angiography at both 3.0 and 1.5 T; imaging examinations were performed within 14 days of each other. Maximum intensity projections (MIPs) obtained with MR angiography performed at both 3.0 and 1.5 T were evaluated by two neuroradiologists; the visualization of moyamoya vessels was graded according to a 4-point scale. For both 3.0- and 1.5-T imaging, the number of high-signal-intensity areas and the summation of cross-sectional areas of high signal intensity on source images obtained at the same level of MR angiography were compared quantitatively by using the Wilcoxon matched-pair signed-rank test.

Results: Moyamoya vessels were better visualized on MIPs obtained with 3.0-T imaging than on MIPs obtained with 1.5-T imaging (P < .001). At the identical level of the source image, 3.0-T imaging depicted more high-signal-intensity areas than did 1.5-T imaging. Wider cross-sectional areas of moyamoya vessels were visualized with 3.0-T imaging than with 1.5-T imaging (P < .001).

Conclusion: Moyamoya vessels are better depicted with MR angiography at 3.0 T than at 1.5 T.

© RSNA, 2006

This article has been cited by other articles:

				C. K. Kuhl, F. Traber, and H. H. Schild Whole-Body High-Field-Strength (3.0-T) MR Imaging in Clinical Practice * Part I. Technical Considerations and Clinical Applications Radiology, March 1, 2008; 246(3): 675 - 696. [Abstract] [Full Text] [PDF]